AbbVie Inc.'s stock rose 4% early Friday, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth needed to ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

Cantor Fitzgerald analysts initiated coverage of Acrivon Therapeutics Inc (NASDAQ:ACRV) with an Overweight rating. The initiation comes with a positive outlook on the company's potential in the ...

Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past decade, according to retrospective ...

A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients.

A recent survey revealed that many patients were worried about the physical effects of radiation, and more than one third ...

The Oncology Institute, Inc.’s TOI share price has surged by 20.24%, which has investors questioning if this is right time to sell.

Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based ...

The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results ...

Kazia Therapeutics is at the forefront of developing cutting-edge cancer therapies, with a key focus on brain cancer and aggressive tumor types like triple-negative breast cancer. The company’s ...

In this webinar, Ethan Shelkey and Aurita Menezes will highlight key aspects in the design of cell-based assays.